Open Access

[Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma

  • Authors:
    • Yahui Liu
    • Wei Zhang
    • Songyang Liu
    • Kai Liu
    • Bai Ji
    • Yingchao Wang
  • View Affiliations

  • Published online on: September 12, 2022     https://doi.org/10.3892/or.2022.8402
  • Article Number: 187
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

November-2022
Volume 48 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu Y, Zhang W, Liu S, Liu K, Ji B and Wang Y: [Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma. Oncol Rep 48: 187, 2022.
APA
Liu, Y., Zhang, W., Liu, S., Liu, K., Ji, B., & Wang, Y. (2022). [Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma. Oncology Reports, 48, 187. https://doi.org/10.3892/or.2022.8402
MLA
Liu, Y., Zhang, W., Liu, S., Liu, K., Ji, B., Wang, Y."[Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma". Oncology Reports 48.5 (2022): 187.
Chicago
Liu, Y., Zhang, W., Liu, S., Liu, K., Ji, B., Wang, Y."[Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma". Oncology Reports 48, no. 5 (2022): 187. https://doi.org/10.3892/or.2022.8402